Search:

Clinical Trials & Medical Discoveries Headlines from PR Newswire


< Go Back

Study on Efficacy and Sedation-Related Safety of Flibanserin in Premenopausal Women Released Today at Sexual Medicine Society of North America Meeting
Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment
Pacific Shore Holdings, Inc. Engages Madison Street Capital As Its Exclusive Investment Banker
Particle Sciences' Clinical Trial Supplies Group Manufactures Innovative Vaginal Ring
Kalorama: Stem Cell Therapies Hold Hope for Alzheimer's Treatments
BioSpecifics Technologies Corp. Announces New Data on XIAFLEX® for Peyronie's Disease Presented at SMSNA Scientific Meeting
CHMP Grants Positive Opinions of AbbVie's VIEKIRAX™ (ombitasvir/paritaprevir/ritonavir) + EXVIERA™ (dasabuvir) for the Treatment of Chronic Hepatitis C in Europe
Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva Spanish
LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference
Coqui RadioPharmaceuticals Inks Deal With INVAP
ISIS-STAT3 Rx and ISIS-AR Rx Data Presented by AstraZeneca at European Cancer Symposium
Project Innovation Launches the Cancer Medicines Interactive Timeline to Highlight the Need for Continued Cancer Innovation in the U.S.
Polaris Group Announces Treatment of First Patient in Phase 1 Study of ADI-PEG 20 plus Pemetrexed and Cisplatin in Malignant Pleural Mesothelioma And Non-Squamous Non-Small Cell Lung Carcinoma
Meditation at Work: Managing Your Mind to Manage Information, latest Blue Paper from 4imprint
Blueprint Medicines Unveils New Drug Discovery Program for Patients with RET Fusions at 26th EORTC-NCI-AACR Symposium
Anthera and Patheon Sign Manufacturing Agreement for Liprotamase Phase III Registration Trial
New Kidney Research Focuses on Rare Disease, FSGS
Benefunder Explores Role of Philanthropy in Fueling Innovation During World Stem Cell Summit
Highland Therapeutics Receives Second Notice of Allowance for Patent on Lead Product
Cardioxyl HNO Prodrugs Show Effectiveness In Preclinical Models Following Oral Administration, Improve Hemodynamics In Chronic Diastolic Dysfunction
Trovagene Releases Clinical Study Results for the Detection and Monitoring of KRAS Mutations in Circulating Tumor DNA of Colorectal Cancer Patients
Beactica Awarded Funding to Develop Epigenetic Cancer Drugs
Nektar Presents Preclinical Study Findings for Etirinotecan Pegol (NKTR-102) in Combination with a PARP Inhibitor in BRCA1-deficient Cancer Model
Neurotrope Announces Last Patient Dosed in Phase 2a Clinical Trial of Bryostatin-1 for Alzheimer's Disease
Inovio Pharmaceuticals Melanoma DNA Immunotherapy Inhibits Tumor Growth and Increases Survival in Preclinical Study
SonicOne® Study Shows Improved Wound Healing In Patients with Peripheral Vascular Disease
Auxilium Pharmaceuticals, Inc. Presents XIAFLEX For Peyronie's Disease Data At SMSNA Scientific Meeting
Transition Therapeutics Announces Results from ELND005 Clinical Study in Adults with Down Syndrome
Gene therapy provides safe, long-term relief for patients with severe hemophilia B
Familial Mediterranean Fever Global Clinical Trials Review, H2, 2014
Zyga Technology Announces First Commercial Implantation and Publication of 12-month Clinical Study Data for Glyder Facet Restoration Device
Experts from The Children's Hospital of Philadelphia Highlight Advances in Pediatric Heart Disease at A.H.A. Scientific Sessions
MabVax Therapeutics And Memorial Sloan-Kettering Cancer Center Report on Potential Use of Dual-Labeled Antibody To Detect and Guide Surgical Removal of Pancreatic Cancer
Successful Outcome Prompts Early End to Sickle Cell Anemia Clinical Trial
New Data From Evolve Clinical Program Demonstrate SYNERGY™ Bioabsorbable Polymer Stent Meets Key Performance Endpoints
3-V Biosciences Announces Presentation of First Human Clinical Data for Lead Oral FASN Inhibitor Candidate at EORTC-NCI-AACR 2014
N30 Pharmaceuticals Secures $30 Million in Oversubscribed Crossover Financing
Janssen Submits New Drug Application to U.S. FDA for Three-Month Paliperidone Palmitate
CDISC and TransCelerate Announce Availability of New Standards for Diabetes and Cardiovascular Disease
Regeneron and Sanofi Announce New Results from Six Phase 3 Trials Showing that Alirocumab Significantly Reduced LDL Cholesterol
Sanofi and Regeneron Announce New Results from Six Phase 3 Trials Showing that Alirocumab Significantly Reduced LDL Cholesterol
Results from Second Oncotype DX® Prostate Cancer Test Clinical Validation and First Decision Impact Study To Be Published in European Urology and Urology Practice, Respectively
New Data From Nonclinical Heart Failure Study To Be Presented At American Heart Association Conference
Otologic Pharmaceutics (OPI) Initiates Phase 1 Clinical Study of HNPN-1010 for Hearing Disorders
Presentations at 26th EORTC-NCI-AACR Symposium Highlight Champions Oncology TumorGrafts' Ability to Evaluate Immune-Modulating Therapies and Guide Clinical Development Strategies
Spinal Muscular Atrophy Program Enters Phase 1b/2a Trial in Patients with SMA
NeuroSigma Congratulates Brazilian Medical Team for Their Top-Line Results in Phase II Clinical Trial of eTNS for Treatment of Depression
BerGenBio Receives Orphan-drug Designation from FDA for BGB324 in the Treatment of Acute Myeloid Leukaemia
Sangamo BioSciences Presents Study At Society For Neuroscience Meeting Demonstrating In Vivo Reversal Of Huntington's Disease Signs And Symptoms
Cordis Corporation Leads With Strong Podium Presence At VEITH 2014 With First-Ever Presentation Of Three-Year INCRAFT® System Data

< Prev Next >
PR Newswire - United Business Media